The Aortic Valve Replacement Devices Market is witnessing strong growth due to the rising prevalence of cardiovascular diseases, increasing geriatric population, and rapid advancements in minimally invasive cardiac procedures. Aortic valve replacement is a life-saving intervention for patients suffering from aortic stenosis and other valve-related disorders, conditions that are becoming increasingly common with aging populations worldwide.

In 2025, the aortic valve replacement devices market reached a value of USD 9.57 billion. With continuous innovation in valve technologies and a growing preference for less invasive procedures, the market is projected to expand at a CAGR of 6.50% from 2026 to 2035, reaching USD 17.96 billion by 2035.

Rising awareness about early diagnosis, increasing adoption of transcatheter procedures, and improved healthcare infrastructure across developed and emerging economies are major factors contributing to this market’s expansion.

Aortic Valve Replacement Devices Market Overview

The Aortic Valve Replacement Devices Market includes medical devices used to replace malfunctioning aortic valves through either surgical or minimally invasive approaches. These devices are critical for restoring normal blood flow from the heart to the rest of the body and reducing the risk of heart failure, stroke, and sudden cardiac death.

The market has evolved significantly over the last decade with the introduction of transcatheter aortic valve replacement (TAVR) technologies, which offer reduced recovery time and lower procedural risks compared to traditional open-heart surgery.

Key growth drivers include:

  • Rising prevalence of aortic stenosis

  • Growing elderly population

  • Technological advancements in heart valve devices

  • Increased preference for minimally invasive surgery

  • Improved reimbursement policies in developed regions

Aortic Valve Replacement Devices Market by Surgery Type

Open Surgery

Open surgical aortic valve replacement (SAVR) has long been the standard treatment for severe aortic valve diseases. This approach involves open-heart surgery and cardiopulmonary bypass to replace the damaged valve.

Despite the rise of minimally invasive alternatives, open surgery remains relevant due to:

  • Long-term durability of surgically implanted valves

  • Suitability for younger and lower-risk patients

  • Better outcomes in complex cardiac conditions

However, longer hospital stays and higher surgical risk limit its use among elderly and high-risk patients.

Minimally Invasive Surgery

Minimally invasive procedures, particularly transcatheter aortic valve replacement (TAVR), are driving significant growth in the aortic valve replacement devices market. These procedures involve catheter-based valve implantation without open-heart surgery.

Key advantages include:

  • Shorter hospital stays

  • Reduced recovery time

  • Lower risk of complications

  • Suitability for elderly and high-risk patients

The growing acceptance of minimally invasive techniques is a major contributor to the rapid expansion of this market segment.

Aortic Valve Replacement Devices Market by Product Type

Transcatheter Aortic Valve

Transcatheter aortic valve replacement devices dominate the market due to their widespread adoption in treating severe aortic stenosis. These devices are delivered through blood vessels and expanded inside the diseased valve.

Benefits include:

  • Reduced surgical trauma

  • Faster patient recovery

  • Lower mortality rates

  • Increasing use in intermediate- and low-risk patients

Technological improvements in valve design and delivery systems continue to expand the clinical applicability of TAVR procedures.

Sutureless Aortic Valve Replacement (SUAVR)

Sutureless aortic valve replacement devices are gaining popularity due to reduced operative time and improved procedural efficiency. These valves are implanted without traditional suturing, minimizing cardiopulmonary bypass duration.

SUAVR is particularly beneficial for:

  • Elderly patients

  • Patients undergoing multiple cardiac procedures

  • Cases requiring reduced surgery time

The growing adoption of hybrid operating rooms is further supporting the use of sutureless valve technologies.

Aortic Valve Replacement Devices Market by End Use

Hospitals

Hospitals account for the largest share of the aortic valve replacement devices market. This dominance is attributed to:

  • Availability of advanced surgical infrastructure

  • Presence of skilled cardiac surgeons

  • Access to intensive care units

  • High patient volume

Most complex valve replacement procedures are performed in hospital settings.

Ambulatory Surgical Centres

Ambulatory surgical centres are gaining traction due to:

  • Shorter hospital stays

  • Lower procedural costs

  • Increasing adoption of minimally invasive procedures

While still limited compared to hospitals, this segment is expected to grow steadily in the coming years.

Others

This category includes specialty cardiac centers and academic institutions involved in advanced cardiovascular research and training.

Aortic Valve Replacement Devices Market by Region

North America

North America leads the global aortic valve replacement devices market due to:

  • High prevalence of cardiovascular diseases

  • Advanced healthcare infrastructure

  • Strong presence of key market players

  • Favorable reimbursement policies

The United States accounts for the largest share, driven by early adoption of transcatheter technologies.

Europe

Europe represents a significant share of the market, supported by:

  • Aging population

  • High awareness of heart valve diseases

  • Strong regulatory framework

  • Growing adoption of minimally invasive procedures

Countries such as Germany, France, and the UK are key contributors.

Asia Pacific

Asia Pacific is the fastest-growing regional market due to:

  • Rapidly aging population

  • Increasing healthcare expenditure

  • Expanding access to cardiac care

  • Growing medical tourism

China, India, and Japan are emerging as major markets for aortic valve replacement devices.

Latin America

The market in Latin America is growing steadily with improving healthcare infrastructure and increasing adoption of advanced cardiovascular treatments.

Middle East and Africa

This region is experiencing moderate growth driven by:

  • Rising investment in healthcare

  • Expansion of private hospitals

  • Increasing awareness of cardiovascular diseases

Competitive Landscape of the Aortic Valve Replacement Devices Market

The market is highly competitive and characterized by continuous innovation, mergers, and product launches.

Key Companies Covered:

  • Boston Scientific Corporation

  • Corcym S.r.l

  • Edwards Lifesciences Corporation

  • Medtronic plc

  • Artivion, Inc.

  • Abbott Laboratories

These companies focus on developing next-generation valve technologies, expanding clinical indications, and improving patient outcomes.

Future Outlook of the Aortic Valve Replacement Devices Market

The future of the aortic valve replacement devices market appears highly promising due to:

  • Expanding geriatric population

  • Growing preference for minimally invasive procedures

  • Technological advancements in valve materials

  • Increased global healthcare spending

  • Expanding clinical indications for TAVR

Innovations such as biodegradable valves, AI-assisted imaging, and robotic-assisted implantation are expected to further transform the market landscape over the next decade.

Frequently Asked Questions (FAQs)

1. What is the Aortic Valve Replacement Devices Market?

The Aortic Valve Replacement Devices Market includes medical devices used to replace damaged aortic valves through surgical or minimally invasive procedures.

2. What is the current size of the Aortic Valve Replacement Devices Market?

The market was valued at USD 9.57 billion in 2025 and is expected to reach USD 17.96 billion by 2035, growing at a CAGR of 6.50%.

3. What are the main types of aortic valve replacement devices?

The main types include transcatheter aortic valves and sutureless aortic valve replacement devices.

4. Which region dominates the aortic valve replacement devices market?

North America dominates due to advanced healthcare infrastructure, high disease prevalence, and strong adoption of innovative cardiac technologies.

5. What factors are driving market growth?

Key drivers include rising cardiovascular disease cases, increasing elderly population, technological advancements, and growing preference for minimally invasive procedures.